Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HL-1186 in Postherpetic Neuralgia
NCT07758920Phase 2Recruiting
- Sponsor
- Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
- Start
- Aug 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
A Phase 2 trial of HL-1186 in postherpetic neuralgia (PHN), sponsored by Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.. Started Aug 2026; status: recruiting.
02
Drugs
HL-1186
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT07758920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07758920.